Nearly four years after Merck & Co. yanked the painkiller Vioxx off the market, beleaguered pharmaceutical-industry executives say they are facing a tough new regulatory climate that is altering the landscape of drug development. Over the past 16 Read More

Detroit —- Toyota Motor Corp. could overtake General Motors Corp. in monthly U.S. sales for the first time in June, but the victory could be hollow as the weak economy continues to pummel the auto industry and even Toyota struggles to meet U.S Read More

An “intensifying focus on safety and a diminished tolerance for side effects” by FDA have “dramatically lowered” the chances that experimental medications will reach the market and have led to a recent decrease in approvals of new treatments Read More

This entry was posted on Tuesday, July 1st, 2008 at 7:34 am and is filed under Vioxx. You can follow any responses to this entry through the RSS 2.0 feed. You can leave a response, or trackback from your own site.